Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2013 Jun 11;94(4):525–532. doi: 10.1038/clpt.2013.119

Figure 1.

Figure 1

Data represents standardized mean and standard error of metabolite levels before (blue) and after (red) aspirin therapy in good vs. poor responders. Metabolites in bold were measured in this study. #:p<0.05 for testing the difference in metabolite levels after vs. before aspirin. *:p<0.05 for testing the difference in metabolite levels in good vs. poor responders. Key: ATP, ADP and AMP: adenosine tri-, di- and mono-phosphate, AMPS: adenylosuccinate, IMP: inosine monophosphate, XMP: xanthosine monophosphate, GTP, GDP, GMP: guanosine tri-, di- and monophosphate, ADK: adenosine kinase.